Source:http://linkedlifedata.com/resource/pubmed/id/16240674
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-10-24
|
pubmed:abstractText |
Patients previously not treated with a lipid-lowering agent (n = 20; mean age 49.15 +/- 3.28 years) were treated with either 10 mg/day of Simvastatin (n = 11), or Atorvastatin (n = 9) for 4 months. Fourteen additional patients were recruited from the same clinic at the same hospital as a control group. The medication of these latter patients was unaltered for 4 months and the same parameters were measured as for the statin groups. Serum concentrations of zinc, copper, caeruloplasmin, selenium, glutathione peroxidase (GPx) and C-reactive protein (CRP) were measured together with their lipid profiles pre- and post-treatment. In addition to reducing serum total and low-density lipoprotein (LDL) cholesterol (p < 0.0001), statin treatment was associated with a significant reduction in mean serum zinc (9%, p = 0.03), copper (9%, p < 0.01), caeruloplasmin (24%, p < 0.05), and median CRP (45%, p < 0.03). Similar changes were not observed in the control patients. No significant effects were observed for serum selenium, copper/caeruloplasmin ratio, or GPx (p > 0.05) in either statin or control groups. These changes may be related to the known anti-inflammatory properties of the statin class of drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Ceruloplasmin,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Trace Elements,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0946-672X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16240674-Adult,
pubmed-meshheading:16240674-Antioxidants,
pubmed-meshheading:16240674-Blood Chemical Analysis,
pubmed-meshheading:16240674-Ceruloplasmin,
pubmed-meshheading:16240674-Female,
pubmed-meshheading:16240674-Heptanoic Acids,
pubmed-meshheading:16240674-Humans,
pubmed-meshheading:16240674-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16240674-Hyperlipidemias,
pubmed-meshheading:16240674-Inflammation,
pubmed-meshheading:16240674-Lipids,
pubmed-meshheading:16240674-Male,
pubmed-meshheading:16240674-Middle Aged,
pubmed-meshheading:16240674-Pyrroles,
pubmed-meshheading:16240674-Simvastatin,
pubmed-meshheading:16240674-Trace Elements
|
pubmed:year |
2005
|
pubmed:articleTitle |
Effect of statin therapy on serum trace element status in dyslipidaemic subjects.
|
pubmed:affiliation |
Centre for Clinical Science & Measurement, School of Biomedical & Molecular Science, University of Surrey, Guildford, Surrey GU2 7XH, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|